Showing results 50 to 61 of 61
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
| 2005 | 96 | |||
| 2020 | 10 | |||
Significance of p73 in the sensitivity of cancer treatment in gynaecological cancers Proceeding/Conference:Croucher ASI Conference on Tumour Microenvironment: New Concepts & Molecular Mechanisms | 2012 | |||
TAp73a enhances the cellular chemosensitivity to cisplatin in ovarian cancer cells Proceeding/Conference:American Association for Cancer Research Annual Meeting, AACR 2010 | 2010 | 95 | ||
TAp73a enhances the cellular chemosensitivity to cisplatin in ovarian cancer cells Proceeding/Conference:HKICC / RCC 2009 | 2009 | 123 | ||
Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer Journal:Journal of Endocrinology | 2014 | 78 | ||
| 2012 | 64 | |||
| 2019 | 255 | |||
| 2006 | 148 | |||
Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma Proceeding/Conference:Inaugural Queenstown Signal Transduction Meeting | 2006 | 147 | ||
The upregulation of PFKFB3/PDK4 enhances ovarian cancer stemness properties in tumor progression Proceeding/Conference:The 17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2018) | 2018 | |||
Use of highly selective estrogen receptor modulators in ovarian caner Proceeding/Conference:International Symposium on Hormonal Oncogenesis, ISHO 2010 | 2010 | 79 |